Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment

Neurobiology of Disease

Volumn 23, Issue 3, 2006, Pages 512-521

  Chepkova, Aisa N ^a   Sergeeva, Olga A ^a   Haas, Helmut L ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antioxidants; Hepatic encephalopathy; Hippocampal slices; Hyperammonemia; l carnitine; Long term potentiation (LTP); Mouse; Taurine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMMONIUM CHLORIDE; ANTIOXIDANT; ASCORBIC ACID; BETAINE; CARNITINE; CARNOSINE; GLYCINE RECEPTOR; GVS 111; TAURINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL FUNCTION; CONTROLLED STUDY; HIPPOCAMPUS; HYPERAMMONEMIA; LONG TERM POTENTIATION; MALE; MITOCHONDRION; MOUSE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

AMMONIUM CHLORIDE; ANIMALS; CARNITINE; ENERGY METABOLISM; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; HYPERAMMONEMIA; LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; RECEPTORS, GABA-A; RECEPTORS, GLYCINE; TAURINE;

EID: 33747190865     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.04.006     Document Type: Article

References (81)

1. Aguilar M.A., Minarro J., and Felipo V. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp. Neurol. 161 (2000) 704-713
2. Albrecht J. Roles of neuroactive amino acids in ammonia neurotoxicity. J. Neurosci. Res. 51 (1998) 133-138
3. Albrecht J., and Jones E.A. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci. 170 (1999) 138-146
4. Albrecht J., and Zielinska M. The role of inhibitory amino acidergic neurotransmission in hepatic encephalopathy: a critical overview. Metab. Brain Dis. 17 (2002) 283-294
5. Arundine M., and Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34 (2003) 325-337
6. Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med. J. 45 (2004) 776-788
7. Balkan J., Dogru-Abbasoglu S., Kanbagli O., Cevikbas U., Aykac-Toker G., and Uysal M. Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum. Exp. Toxicol. 20 (2001) 251-254
8. Bashir Z.I., Bortolotto Z.A., Davies C.H., Berretta N., Irving A.J., Seal A.J., Henley J.M., Jane D.E., Watkins J.C., and Collingridge G.L. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature 363 (1993) 347-350
9. Birdsall T.C. Therapeutic applications of taurine. Alt. Med. Rev. 3 (1998) 128-136
10. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
11. Boldyrev A.A., Stvolinsky S.L., Tyulina O.V., Koshelev V.B., Hori N., and Carpenter D.O. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell. Mol. Neurobiol. 17 (1997) 259-271
12. Boldyrev A.A., Johnson P., Wei Y., Tan Y., and Carpenter D.O. Carnosine and taurine protect rat cerebellar granular cells from free radical damage. Neurosci. Lett. 263 (1999) 169-172
13. Butterworth R.F. Glutamate transporter and receptor function in disorders of ammonia metabolism. Ment. Retard. Dev. Disabil. Res. Rev. 7 (2001) 276-279
14. Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab. Brain Dis. 17 (2002) 221-227
15. Chan H., Hazell A.S., Desjardins P., and Butterworth R.F. Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes. Neurochem. Int. 37 (2000) 243-248
16. Chang L., Xu J.X., Zhao J., Pang Y.Z., Tang C.S., and Qi Y.F. Taurine antagonized oxidative stress injury induced by homocysteine in rat vascular smooth muscle cells. Acta Pharmacol. Sin. 25 (2004) 341-346
17. Chattipakorn S.C., and McMahon L.L. Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices. J. Neurophysiol. 87 (2002) 1515-1525
18. Chen W.Q., Jin H., Nguyen M., Carr J., Lee Y.J., Hsu C.C., Faiman M.D., Schloss J.V., and Wu J.Y. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J. Neurosci. Res. 66 (2001) 612-619
19. Chepkova A.N., Doreulee N., Yanovsky Y., Mukhopadhyay D., Haas H.L., and Sergeeva O.A. Long-lasting enhancement of corticostriatal neurotransmission by taurine. Eur. J. Neurosci. 16 (2002) 1523-1530
20. Dawson R., Biasetti M., Messina S., and Dominy J. The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids 22 (2002) 309-324
21. del Olmo N., Bustamante J., del Rio R.M., and Solis J.M. Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area. Brain Res. 864 (2000) 298-307
22. del Olmo N., Handler A., Alvarez L., Bustamante J., Martin d.R., and Solis J.M. Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically. Neuropharmacology 44 (2003) 26-39
23. del Olmo N., Suarez L.M., Orensanz L.M., Suarez F., Bustamante J., Duarte J.M., Martin D.R., and Solis J.M. Role of taurine uptake on the induction of long-term synaptic potentiation. Eur. J. Neurosci. 19 (2004) 1875-1886
24. Duchen M.R. Mitochondria and calcium: from cell signalling to cell death. J. Physiol. 529 Pt 1 (2000) 57-68
25. El Abhar H.S., and El Gawad H.M. Modulation of cortical nitric oxide synthase, glutamate, and redox state by nifedipine and taurine in PTZ-kindled mice. Epilepsia 44 (2003) 276-281
26. El Idrissi A., and Trenkner E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 19 (1999) 9459-9468
27. Felipo V., and Butterworth R.F. Mitochondrial dysfunction in acute hyperammonemia. Neurochem. Int. 40 (2002) 487-491
28. Foos T.M., and Wu J.Y. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem. Res. 27 (2002) 21-26
29. Galarreta M., Bustamante J., Martin d.R., and Solis J.M. Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J. Neurosci. 16 (1996) 92-102
30. Gurer H., Ozgunes H., Saygin E., and Ercal N. Antioxidant effect of taurine against lead-induced oxidative stress. Arch. Environ. Contam. Toxicol. 41 (2001) 397-402
31. Haussinger, D., Schliess, F., Kircheis, G., 2002. Pathogenesis of hepatic encephalopathy. J. Gastroenterol. Hepatol. 17 (Suppl. 3) S256-S259.
32. Hayes J., Tipton K.F., Bianchi L., and Corte L.D. Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine. Brain Res. Bull. 55 (2001) 239-245
33. Hazell A.S., and Butterworth R.F. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc. Soc. Exp. Biol. Med. 222 (1999) 99-112
34. Hermenegildo C., Montoliu C., Llansola M., Munoz M.D., Gaztelu J.M., Minana M.D., and Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur. J. Neurosci. 10 (1998) 3201-3209
35. Hilgier W., Anderzhanova E., Oja S.S., Saransaari P., and Albrecht J. Taurine reduces ammonia- and N-methyl-d-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. Eur. J. Pharmacol. 468 (2003) 21-25
36. Hilgier W., Oja S.S., Saransaari P., and Albrecht J. Taurine prevents ammonia-induced accumulation of cyclic GMP in rat striatum by interaction with GABAA and glycine receptors. Brain Res. 1043 (2005) 242-246
37. Hino K., Nishikawa M., Sato E., and Inoue M. l-carnitine inhibits hypoglycemia-induced brain damage in the rat. Brain Res. 1053 (2005) 77-87
38. Hogema B.M., Gupta M., Senephansiri H., Burlingame T.G., Taylor M., Jakobs C., Schutgens R.B., Froestl W., Snead O.C., Diaz-Arrastia R., Bottiglieri T., Grompe M., and Gibson K.M. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat. Genet. 29 (2001) 212-216
39. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72 (1992) 101-163
40. Izumi Y., Izumi M., Matsukawa M., Funatsu M., and Zorumski C.F. Ammonia-mediated LTP inhibition: Effects of NMDA receptor antagonists and l-carnitine. Neurobiol. Dis. 20 (2005) 615-624
41. Kloiber O., Banjac B., and Drewes L.R. Protection against acute hyperammonemia: the role of quaternary amines. Toxicology 49 (1988) 83-90
42. Knecht K., Michalak A., Rose C., Rothstein J.D., and Butterworth R.F. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci. Lett. 229 (1997) 201-203
43. Kosenko E., Kaminsky Y., Grau E., Minana M.D., Marcaida G., Grisolia S., and Felipo V. Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and Na+,K(+)-ATPase. J. Neurochem. 63 (1994) 2172-2178
44. Kosenko E., Kaminsky Y., Kaminsky A., Valencia M., Lee L., Hermenegildo C., and Felipo V. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic. Res. 27 (1997) 637-644
45. Kosenko E., Kaminsky Y., Stavroskaya I.G., and Felipo V. Alteration of mitochondrial calcium homeostasis by ammonia-induced activation of NMDA receptors in rat brain in vivo. Brain Res. 880 (2000) 139-146
46. Kosenko E., Venediktova N., Kaminsky Y., Montoliu C., and Felipo V. Sources of oxygen radicals in brain in acute ammonia intoxication in vivo. Brain Res. 981 (2003) 193-200
47. Levy M., Faas G.C., Saggau P., Craigen W.J., and Sweatt J.D. Mitochondrial regulation of synaptic plasticity in the hippocampus. J. Biol. Chem. 278 (2003) 17727-17734
48. Llansola M., Erceg S., Hernandez-Viadel M., and Felipo V. Prevention of ammonia and glutamate neurotoxicity by carnitine: molecular mechanisms. Metab. Brain Dis. 17 (2002) 389-397
49. Majewska M.D., and Bell J.A. Ascorbic acid protects neurons from injury induced by glutamate and NMDA. NeuroReport 1 (1990) 194-196
50. Malaguarnera M., Pistone G., Astuto M., Dell'Arte S., Finocchiaro G., Lo G.E., and Pennisi G. l-Carnitine in the treatment of mild or moderate hepatic encephalopathy. Dig. Dis. 21 (2003) 271-275
51. Marcaida G., Minana M.D., Burgal M., Grisolia S., and Felipo V. Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures. Eur. J. Neurosci. 7 (1995) 2389-2396
52. Minana M.D., Hermenegildo C., Llsansola M., Montoliu C., Grisolia S., and Felipo V. Carnitine and choline derivatives containing a trimethylamine group prevent ammonia toxicity in mice and glutamate toxicity in primary cultures of neurons. J. Pharmacol. Exp. Ther. 279 (1996) 194-199
53. Monfort P., Munoz M.D., ElAyadi A., Kosenko E., and Felipo V. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab. Brain Dis. 17 (2002) 237-250
54. Monfort P., Munoz M.D., Kosenko E., and Felipo V. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J. Neurosci. 22 (2002) 10116-10122
55. Mori M., Gahwiler B.H., and Gerber U. Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J. Physiol. 539 (2002) 191-200
56. Munoz M.D., Monfort P., Gaztelu J.M., and Felipo V. Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem. Res. 25 (2000) 437-441
57. Norenberg M.D. Oxidative and nitrosative stress in ammonia neurotoxicity. Hepatology 37 (2003) 245-248
58. Obrosova I.G., Fathallah L., and Stevens M.J. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp. Neurol. 172 (2001) 211-219
59. O'Byrne M.B., and Tipton K.F. Taurine-induced attenuation of MPP+ neurotoxicity in vitro: a possible role for the GABA(A) subclass of GABA receptors. J. Neurochem. 74 (2000) 2087-2093
60. O'Connor J.E., and Costell M. New roles of carnitine metabolism in ammonia cytotoxicity. Adv. Exp. Med. Biol. 272 (1990) 183-195
61. Palmi M., Youmbi G.T., Fusi F., Sgaragli G.P., Dixon H.B., Frosini M., and Tipton K.F. Potentiation of mitochondrial Ca2+ sequestration by taurine. Biochem. Pharmacol. 58 (1999) 1123-1131
62. Paula-Lima A.C., De Felice F.G., Brito-Moreira J., and Ferreira S.T. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 49 (2005) 1140-1148
63. Pelsman A., Hoyo-Vadillo C., Gudasheva T.A., Seredenin S.B., Ostrovskaya R.U., and Busciglio J. GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. Int. J. Dev. Neurosci. 21 (2003) 117-124
64. Rao K.V., Mawal Y.R., and Qureshi I.A. Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-l-carnitine in restoring the ammonia-induced cerebral energy depletion. Neurosci. Lett. 224 (1997) 83-86
65. Raymond C.R., Thompson V.L., Tate W.P., and Abraham W.C. Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation. J. Neurosci. 20 (2000) 969-976
66. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23 (2000) 209-216
67. Rivas-Arancibia S., Rodriguez A.I., Zigova T., Willing A.E., Brown W.D., Cahill D.W., and Sanberg P.R. Taurine increases rat survival and reduces striatal damage caused by 3-nitropropionic acid. Int. J. Neurosci. 108 (2001) 55-67
68. Saransaari P., and Oja S.S. Taurine and neural cell damage. Amino Acids 19 (2000) 509-526
69. Sergeeva O.A., Chepkova A.N., Doreulee N., Eriksson K.S., Poelchen W., Monnighoff I., Heller-Stilb B., Warskulat U., Haussinger D., and Haas H.L. Taurine-induced long-lasting enhancement of synaptic transmission in mice: role of transporters. J. Physiol. 550 (2003) 911-919
70. Severina I.S., Bussygina O.G., and Pyatakova N.V. Carnosine as a regulator of soluble guanylate cyclase. Biochemistry (Moscow) 65 (2000) 783-788
71. Song W., Chattipakorn S.C., and McMahon L.L. Glycine-gated chloride channels depress synaptic transmission in rat hippocampus. J. Neurophysiol. 95 (2006) 2366-2379
72. Taber K.H., Lin C.T., Liu J.W., Thalmann R.H., and Wu J.Y. Taurine in hippocampus: localization and postsynaptic action. Brain Res. 386 (1986) 113-121
73. Takahashi K., Kameda H., Kataoka M., Sanjou K., Harata N., and Akaike N. Ammonia potentiates GABAA response in dissociated rat cortical neurons. Neurosci. Lett. 151 (1993) 51-54
74. Therrien G., Rose C., Butterworth J., and Butterworth R.F. Protective effect of l-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat. Hepatology 25 (1997) 551-556
75. Trenkner E., el Idrissi A., and Harris C. Balanced interaction of growth factors and taurine regulate energy metabolism, neuronal survival, and function of cultured mouse cerebellar cells under depolarizing conditions. Adv. Exp. Med. Biol. 403 (1996) 507-517
76. Vogels B.A., Maas M.A., Daalhuisen J., Quack G., and Chamuleau R.A. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 25 (1997) 820-827
77. Williams J.M., Thompson V.L., Mason-Parker S.E., Abraham W.C., and Tate W.P. Synaptic activity-dependent modulation of mitochondrial gene expression in the rat hippocampus. Brain Res. Mol. Brain Res. 60 (1998) 50-56
78. Wilsch V.W., Behnisch T., Jager T., Reymann K.G., and Balschun D. When are class I metabotropic glutamate receptors necessary for long-term potentiation?. J. Neurosci. 18 (1998) 6071-6080
79. 2+ in immature rat hippocampal neurons. Amino Acids 24 (2003) 155-161
80. Zhuo M., Hu Y., Schultz C., Kandel E.R., and Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368 (1994) 635-639
81. Zielinska M., Law R.O., and Albrecht J. Excitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia. Neurochem. Int. 43 (2003) 299-303